Pre-earnings options volume in Actinium Pharmaceuticals is normal with calls leading puts 3:2. Implied volatility suggests the market is anticipating a move near 7.3%, or 92c, after results are released. Median move over the past eight quarters is 3.0%.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ATNM: